These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 14657616)
1. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait. Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
3. Indication of hysteroscopy in tamoxifen treated breast cancer patients. Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527 [TBL] [Abstract][Full Text] [Related]
4. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
5. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881 [TBL] [Abstract][Full Text] [Related]
6. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450 [TBL] [Abstract][Full Text] [Related]
8. Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor-positive breast cancer. López DM; Fernández YG; Sánchez AV; Alvarez MI; Reynaldo MI; Delgado RC Menopause; 2013 Jan; 20(1):64-71. PubMed ID: 22968254 [TBL] [Abstract][Full Text] [Related]
9. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and endometrial pathologies: a prospective study. Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419 [TBL] [Abstract][Full Text] [Related]
11. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen. Zhu Y; Yang J J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697 [TBL] [Abstract][Full Text] [Related]
12. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen. Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703 [TBL] [Abstract][Full Text] [Related]
13. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781 [TBL] [Abstract][Full Text] [Related]
14. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients. Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440 [TBL] [Abstract][Full Text] [Related]
15. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers. Gibson LE; Barakat RR; Venkatraman ES; Hoskins WJ Cancer J Sci Am; 1996; 2(1):35-8. PubMed ID: 9166496 [TBL] [Abstract][Full Text] [Related]
16. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors. Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259 [TBL] [Abstract][Full Text] [Related]
17. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women. Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen. Kesim MD; Aydin Y; Atis A; Mandiraci G Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790 [TBL] [Abstract][Full Text] [Related]